SMOVITAR Trademark

Trademark Overview


On Wednesday, July 20, 2016, a trademark application was filed for SMOVITAR with the United States Patent and Trademark Office. The USPTO has given the SMOVITAR trademark a serial number of 87110334. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Thursday, November 23, 2017. This trademark is owned by Pfizer Inc.. The SMOVITAR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
smovitar

General Information


Serial Number87110334
Word MarkSMOVITAR
Filing DateWednesday, July 20, 2016
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateThursday, November 23, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 13, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateThursday, November 23, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Friday, November 24, 2017ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
Thursday, November 23, 2017ABANDONMENT - AFTER PUBLICATION
Wednesday, November 22, 2017TEAS EXPRESS ABANDONMENT RECEIVED
Wednesday, July 19, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 17, 2017EXTENSION 1 GRANTED
Monday, July 17, 2017EXTENSION 1 FILED
Monday, July 17, 2017TEAS EXTENSION RECEIVED
Tuesday, February 7, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 13, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 13, 2016PUBLISHED FOR OPPOSITION
Wednesday, November 23, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 3, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 31, 2016ASSIGNED TO EXAMINER
Tuesday, July 26, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, July 23, 2016NEW APPLICATION ENTERED IN TRAM